CYP2D6 and Plasmodium vivax malaria: Those failures occurred at a rate of 15% among several hundred such treatments (J. Kevin Baird, personal communication, 2017).1 Impaired CYP2D6 alleles may commonly occur among people at risk of vivax malaria.